This method could be used to replace HLA-DRB1 typing even though it cannot identify the DR3 and DR4 homozygous genotypes that also confer a remarkable risk to type 1 diabetes and it may not be accessible everywhere. This evidence concerns the gene HLA-DRB1 and type 1 diabetes mellitus.